Filing Details
- Accession Number:
- 0000891293-14-000028
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-09-19 19:18:07
- Reporting Period:
- 2014-09-19
- Filing Date:
- 2014-09-19
- Accepted Time:
- 2014-09-19 19:18:07
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 891293 | Cti Biopharma Corp | CTIC | Pharmaceutical Preparations (2834) | 911533912 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1204260 | A Louis Bianco | 3101 Western Ave Suite 600 Seattle WA 98121 | Evp, Finance & Administration | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2014-09-19 | 59,740 | $2.58 | 733,157 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-09-19 | 200 | $2.58 | 732,957 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-09-19 | 12,200 | $2.59 | 720,757 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-09-19 | 37,200 | $2.59 | 683,557 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-09-19 | 3,700 | $2.60 | 679,857 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-09-19 | 14,300 | $2.60 | 665,557 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-09-19 | 2,300 | $2.61 | 663,257 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-09-19 | 9,660 | $2.62 | 653,597 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-09-19 | 100 | $2.63 | 653,497 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-09-19 | 5,600 | $2.68 | 647,897 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 37 | Indirect | Trust for children |
Footnotes
- The sale was effected pursuant to a Rule 10b5-1 trading plan.
Billionaire Hedge Funds
